To be first choice to deliver translational evidence based insights to life science companies and other healthcare pioneers, to help them demonstrate VfM; partner in solving intractable healthcare problems and accelerate patient access.
Our top five evidence generation goals are to:
Create timely and optimal solutions to meet the evidence requirements of healthcare reimbursement, funding and technology appraisal authorities.
Add value to pharmaceutical and medical technology companies and their affiliates, through the whole product lifecycle.
Focus efforts on technologies that deliver value for money to healthcare organisations and their payors.
Discover needs as yet unknown and new opportunities to address healthcare needs as yet unmet.
Pioneer new technologies and streamlined ways to collect, assimilate and analyse biofeedback and clinical, economic and behavioural data.
Collaborate with Research Sponsors; Life Science Companies; Clinical Key Opinion Leaders; Healthcare Policy & Decision Makers; Healthcare Delivery Providers; Universities; Professional Associations; Charities and Patient Advocacy Groups.
REACH OUT TODAY
Arrange a call back...
STAY TUNED IN
Join our global discovery platform. Opt to receive alerts on podcasts, events and other online networking opportunities.
Sign Up Today
We take your privacy very seriously. Your information is never shared for any reason.
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.